BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37893602)

  • 41. The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): Linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South Africa.
    Snyman LC; Dreyer G; Visser C; Botha MH; van der Merwe FH
    S Afr Med J; 2015 Mar; 105(3):191-4. PubMed ID: 26294825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
    Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
    BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
    Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
    BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical cancer screening in rural Ethiopia: a cross- sectional knowledge, attitude and practice study.
    Ruddies F; Gizaw M; Teka B; Thies S; Wienke A; Kaufmann AM; Abebe T; Addissie A; Kantelhardt EJ
    BMC Cancer; 2020 Jun; 20(1):563. PubMed ID: 32552740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
    Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
    BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania.
    Cunningham MS; Skrastins E; Fitzpatrick R; Jindal P; Oneko O; Yeates K; Booth CM; Carpenter J; Aronson KJ
    BMJ Open; 2015 Mar; 5(3):e005828. PubMed ID: 25757944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigating Bangladeshi Rural Women's Awareness and Knowledge of Cervical Cancer and Attitude Towards HPV Vaccination: a Community-Based Cross-Sectional Analysis.
    Banik R; Naher S; Rahman M; Gozal D
    J Cancer Educ; 2022 Apr; 37(2):449-460. PubMed ID: 32734448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
    Syrjänen K
    Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The feasibility of new HPV/DNA test as a primary cervical cancer screening method among 35- years- old ever-married women in Kalutara district; a cross-sectional study.
    Perera KCM; Mapitigama N; Abeysena H
    BMC Public Health; 2021 Jan; 21(1):131. PubMed ID: 33441083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of knowledge about cervical cancer and its prevention among female students aged 17-26 years.
    Kamzol W; Jaglarz K; Tomaszewski KA; Puskulluoglu M; Krzemieniecki K
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):196-203. PubMed ID: 23141797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The rationale for implementation of HPV testing in routine cervical screening in Romania.
    Iancu LS; Ursu RG
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
    [No Abstract]   [Full Text] [Related]  

  • 53. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
    Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
    Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
    BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sexual behaviors and intention for cervical screening among HPV-vaccinated young Chinese females.
    Chua GT; Ho FK; Tung KT; Wong RS; Cheong KN; Yip PS; Fan SY; Wong WH; Qiao Y; Chui CS; Li SX; Ip P
    Vaccine; 2020 Jan; 38(5):1025-1031. PubMed ID: 31786002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study.
    Tranberg M; Petersen LK; Hammer A; Elfström M; Blaakær J; Jørgensen SF; Bennetsen MH; Jensen JS; Andersen B
    PLoS Med; 2023 Jul; 20(7):e1004253. PubMed ID: 37410699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knowledge and experience of cancer prevention and screening among Gypsies, Roma and Travellers: a participatory qualitative study.
    Condon L; Curejova J; Morgan DL; Miles G; Fenlon D
    BMC Public Health; 2021 Feb; 21(1):360. PubMed ID: 33593323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
    Donkoh ET; Asmah RH; Agyemang-Yeboah F; Dabo EO; Wiredu EK
    Cancer Control; 2022; 29():10732748221094721. PubMed ID: 35536890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
    Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
    Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.